Marizomib for central nervous system-multiple myeloma

被引：62

作者：

Badros, Ashraf ^{[1
]}

Singh, Zeba ^{[1
]}

Dhakal, Binod ^{[2
]}

Kwok, Young ^{[1
]}

MacLaren, Ann ^{[3
]}

Richardson, Paul ^{[4
]}

Trikha, Mohit ^{[3
]}

Hari, Parameswaran ^{[2
]}

机构：

[1] Univ Maryland, Med Ctr, M&S Greenebaum Canc Ctr, Baltimore, MD 21201 USA

[2] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI 53226 USA

[3] Triphase Accelerator, San Diego, CA USA

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2017年 / 177卷 / 02期

关键词：

multiple myeloma; central nervous system relapse; clinical studies; marizomib; INVOLVEMENT;

D O I：

10.1111/bjh.14498

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Marizomib, a natural marine product, is an irreversible proteasome inhibitor currently under investigation in relapsed-refractory multiple myeloma (RRMM) and malignant glioma. Central nervous system-multiple myeloma (CNS-MM) is a rare manifestation of extra-medullary disease with few therapeutic options, highlighting the unmet clinical need in these patients. Marizomib demonstrated encouraging activity in RRMM and has emerging clinical activity in glioma, making it a potential CNS-MM therapeutic intervention. Herein, we present two patients with RRMM and CNS involvement who benefited from marizomib-based therapy. Thesecases provide the first proof of principle for further exploring marizomib in CNS-MM patients.

引用

页码：221 / 225

页数：5

共 50 条

[41] Clinical features of multiple myeloma invasion of the central nervous system in Chinese patients
QU XiaoyanFU WeijunXI HaoZHOU FanWEI Wei and HOU Jian Department of HematologyChangzheng HospitalSecond Hospital Affiliated to the Second Military Medical UniversityShanghai China
中华医学杂志（英文版）, 2010, (11) : 1402 - 1406
[42] MULTIPLE MYELOMA WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT, 12 CASES AND REVIEW OF THE LITERATURE
Varga, G.
Mikala, G.
Gopcsa, L.
Csukly, Z.
Remenyi, P.
Szombath, G.
Masszi, A.
Andrikovics, H.
Balazs, G.
Timar, B.
Masszi, T.
HAEMATOLOGICA, 2017, 102 : 787 - 788
[43] FAMILIAL AGGREGATION OF MULTIPLE-MYELOMA AND CENTRAL NERVOUS-SYSTEM DISEASE
GRUFFERMAN, S
COHEN, HJ
MORRISON, MC
DELZELL, ES
SCHOLD, SC
DELONG, ER
CLINICAL RESEARCH, 1982, 30 (02): : A418 - A418
[44] EXTRAMEDULLARY INVOLVEMENT OF CENTRAL NERVOUS SYSTEM IN MULTIPLE MYELOMA: REPORT OF 4 CASES
Rocco, S.
Palmieri, S.
Carbone, A.
Riccardi, C.
Finizio, O.
Copia, C.
Pocali, B.
De Simone, M. C.
Angelillo, P.
Annunziata, M.
Ferrara, F.
HAEMATOLOGICA, 2014, 99 : 655 - 655
[45] Myeloma of the central nervous system - an ongoing conundrum!
Harrison, Simon J.
Spencer, Andrew
Quach, Hang
LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1505 - 1506
[46] Multiple myeloma involving the central nervous system: a report of two cases with unusual manifestations
Pontikoglou, C
Fragos, C
Kolyvaki, E
Samonis, G
Eliopoulos, GD
Papadaki, HA
LEUKEMIA & LYMPHOMA, 2005, 46 (05) : 737 - 741
[47] Imaging of extraosseous intracranial and intraspinal multiple myeloma, including central nervous system involvement
Shpilberg, Katya A.
Esses, Steven J.
Fowkes, Mary E.
Chari, Ajai
Sacher, Michael
Naidich, Thomas P.
CLINICAL IMAGING, 2015, 39 (02) : 213 - 219
[48] Case reports: Central nervous system involvement in patients with newly diagnosed multiple myeloma
Liu, Jinghua
Shen, Jing
Liu, Daihong
FRONTIERS IN NEUROLOGY, 2023, 14
[49] Central Nervous System Invasion in Multiple Myeloma: A Nationwide Survey of 75 Patients in Japan
Yamashita, Takeshi
Takamatsu, Hiroyuki
Kawamura, Koji
Sunami, Kazutaka
Hagiwara, Shotaro
Itagaki, Mitsuhiro
Takahashi, Tsutomu
Kondo, Tadakazu
Ikeda, Takashi
Watakabe-Inamoto, Kyoko
Handa, Hiroshi
Imaizumi, Yoshitaka
Kuroda, Junya
Murakami, Jun
Nakamura, Yuichi
Nakazawa, Hideyuki
Ozaki, Shuji
Nakao, Shinji
Tobinai, Kensei
Iida, Shinsuke
BLOOD, 2016, 128 (22)
[50] Daratumomab for the treatment of relapsed multiple myeloma involving the central nervous system: a case report
Brandt, A.
Seuss, H.
Mackensen, A.
Roesler, W.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 278 - 278

← 1 2 3 4 5 →